Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Buck

Showing results (131-140 of 400) with videos related to

Pageof 40
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|April 25, 2012
PET SUV correlates with radionuclide uptake in peptide receptor therapy in meningiomaHeribert Hänscheid, Reinhart A Sweeney, Michael Flentje, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 18, 2014
The number of 131I therapy courses needed to achieve complete remission is an indicator of prognosis in patients with differentiated thyroid carcinomaElena-Daphne Thies, Karina Tanase, Uwe Maeder, et al.
The Journal of Clinical Endocrinology and Metabolism|November 15, 2012
Life expectancy is reduced in differentiated thyroid cancer patients ≥ 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patientsFrederik A Verburg, Uwe Mäder, Karina Tanase, et al.
Head & Neck|December 31, 2013
Freehand SPECT-guided sentinel lymph node biopsy in early oral squamous cell carcinomaChristina Bluemel, Ken Herrmann, Urs Müller-Richter, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 11, 2022
CXCR4-targeted molecular imaging after severe SARS-Cov-2 infectionAlessandro Lambertini, Philipp E Hartrampf, Takahiro Higuchi, et al.
JACC. Cardiovascular Imaging|December 25, 2015
[(68)Ga]Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial InfarctionConstantin Lapa, Theresa Reiter, Rudolf A Werner, et al.
Seminars in Nuclear Medicine|May 26, 2023
Role of Functional SPECT and PET in Renal EmergenciesTakahiro Higuchi, Philipp E Hartrampf, Andreas K Buck, et al.
Molecular Imaging and Biology|February 9, 2024
Volumetric Parameters Derived from CXCR4-Directed PET/CT Predict Outcome in Patients with Gastrointestinal Neuroendocrine CarcinomasKerstin Michalski, Wiebke Schlötelburg, Philipp Hartrampf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 11, 2002
Initial results in the assessment of multiple myeloma using 18F-FDG PETH Schirrmeister, M Bommer, A K Buck, et al.
Abdominal Imaging|February 8, 2007
Assessment of disease activity in alveolar echinococcosis: a comparison of contrast enhanced ultrasound, three-phase helical CT and [(18)F] fluorodeoxyglucose positron emission tomographyAlexander R Ehrhardt, Stefan Reuter, Andreas K Buck, et al.
Pageof 40

Showing results (131-140 of 400) with videos related to

Sort By:
Pageof 40
European Journal of Nuclear Medicine and Molecular Imaging|April 25, 2012
PET SUV correlates with radionuclide uptake in peptide receptor therapy in meningiomaHeribert Hänscheid, Reinhart A Sweeney, Michael Flentje, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 18, 2014
The number of 131I therapy courses needed to achieve complete remission is an indicator of prognosis in patients with differentiated thyroid carcinomaElena-Daphne Thies, Karina Tanase, Uwe Maeder, et al.
The Journal of Clinical Endocrinology and Metabolism|November 15, 2012
Life expectancy is reduced in differentiated thyroid cancer patients ≥ 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patientsFrederik A Verburg, Uwe Mäder, Karina Tanase, et al.
Head & Neck|December 31, 2013
Freehand SPECT-guided sentinel lymph node biopsy in early oral squamous cell carcinomaChristina Bluemel, Ken Herrmann, Urs Müller-Richter, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 11, 2022
CXCR4-targeted molecular imaging after severe SARS-Cov-2 infectionAlessandro Lambertini, Philipp E Hartrampf, Takahiro Higuchi, et al.
JACC. Cardiovascular Imaging|December 25, 2015
[(68)Ga]Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial InfarctionConstantin Lapa, Theresa Reiter, Rudolf A Werner, et al.
Seminars in Nuclear Medicine|May 26, 2023
Role of Functional SPECT and PET in Renal EmergenciesTakahiro Higuchi, Philipp E Hartrampf, Andreas K Buck, et al.
Molecular Imaging and Biology|February 9, 2024
Volumetric Parameters Derived from CXCR4-Directed PET/CT Predict Outcome in Patients with Gastrointestinal Neuroendocrine CarcinomasKerstin Michalski, Wiebke Schlötelburg, Philipp Hartrampf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 11, 2002
Initial results in the assessment of multiple myeloma using 18F-FDG PETH Schirrmeister, M Bommer, A K Buck, et al.
Abdominal Imaging|February 8, 2007
Assessment of disease activity in alveolar echinococcosis: a comparison of contrast enhanced ultrasound, three-phase helical CT and [(18)F] fluorodeoxyglucose positron emission tomographyAlexander R Ehrhardt, Stefan Reuter, Andreas K Buck, et al.
Pageof 40